Trial Details

Not Recruiting
Basic Information
Clinical ID c5056
Identifier EUCTR2022-000894-16-NL
Trial Title Predicting Response to Iron Supplementation in Patients with active Inflammatory Bowel Disease - PRIme
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease MedDRA version: 20.0 Level: PT Classification code 10022972 Term: Iron deficiency anaemia System Organ Class: 10005329 - Blood and lymphatic system disorders MedDRA version: 20.0_
Interventions Trade Name: FeraccruPharmaceutical Form: Capsule, hardINN or Proposed INN: FERRIC MALTOLCAS Number: 33725-54-1Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 30-Trade Name: Ferinject<br
Participant Information
Sponsor Leiden University Medical Center
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL